APA (7th ed.) Citation

Fadlyana, E., Rusmil, K., Tarigan, R., Rahmadi, A. R., Prodjosoewojo, S., Sofiatin, Y., . . . Kartasasmita, C. B. (2021). A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia. Vaccine, 39(44), 6520-6528. https://doi.org/10.1016/j.vaccine.2021.09.052

Chicago Style (17th ed.) Citation

Fadlyana, Eddy, et al. "A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18–59 years: An Interim Analysis in Indonesia." Vaccine 39, no. 44 (2021): 6520-6528. https://doi.org/10.1016/j.vaccine.2021.09.052.

MLA (9th ed.) Citation

Fadlyana, Eddy, et al. "A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18–59 years: An Interim Analysis in Indonesia." Vaccine, vol. 39, no. 44, 2021, pp. 6520-6528, https://doi.org/10.1016/j.vaccine.2021.09.052.